When did the new requirements for nucleotide and amino acid sequence disclosures in patent applications take effect?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The new requirements for nucleotide and amino acid sequence disclosures…

Read More

How does the ‘No Inter Partes Questions Discussed Ex Parte’ rule affect patent applicants?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The ‘No Inter Partes Questions Discussed Ex Parte’ rule, as…

Read More

What are the consequences of violating the ‘No Inter Partes Questions Discussed Ex Parte’ rule?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Violating the ‘No Inter Partes Questions Discussed Ex Parte’ rule,…

Read More